Sanofi Sues FDA, Claiming Agency Exceeded Its Authority In Approving Enoxaparin
This article was originally published in The Pink Sheet Daily
Executive Summary
Company claims the agency approved the generic although the innovator drug had not been fully characterized, but odds are against a Sanofi win in court.